Literature DB >> 7547504

Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells.

S E Gitelman1, M Kirk, J Q Ye, E H Filvaroff, A J Kahn, R Derynck.   

Abstract

The transforming growth factor-beta (TGF-beta) superfamily is a group of secreted growth factors that appears to play a central role in mesenchymal differentiation, including cartilage and bone formation. The present study examines the role of one member of this family, vgr-1, also called bone morphogenetic protein-6, in mesenchymal cell differentiation. This factor may be considered as a prototype for the largest subgroup of related factors within the TGF-beta superfamily, the function of which has as yet been poorly defined. vgr-1 has been localized previously to hypertrophic cartilage and has been shown to induce endochondral bone formation in vivo. To further characterize the role of vgr-1 in bone and cartilage differentiation, we stably transfected the pluripotent mesenchymal cell line ROB-C26 with a vector to overexpress vgr-1. Overexpression of this factor did not affect cell shape or morphology, but it enhanced osteoblastic differentiation in vitro and altered cellular responsiveness to retinoic acid. Furthermore, the extracellular matrix produced by these vgr-1-overexpressing cells induced ectopic bone formation in vivo and osteoblastic differentiation in vitro, similar to the matrix produced by C26 cells treated with retinoic acid. The osteoinductive effect of the matrix from vgr-1-overexpressing cells was blocked using a neutralizing vgr-1 antibody but not with a neutralizing TGF-beta 1 antibody, indicating that vgr-1 alone was required for this osteogenic effect. In contrast, the osteoinductive effect of matrix from retinoic acid-treated cells was blocked with both vgr-1 and TGF-beta 1 antibodies, suggesting that TGF-beta 1 may act prior to vgr-1 during osteoblastic differentiation. We further demonstrated that osteoinduction by vgr-1 was dependent on presentation of vgr-1 within the matrix, because the osteoinductive effect of matrix from vgr-1-overexpressing cells could not be mimicked with the addition of soluble vgr-1 to parental C26 cells. Finally, overexpression of MyoD within the C26 cells overexpressing vgr-1 converted the cells to myoblasts, indicating that vgr-1 had induced early osteoblastic.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547504

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

1.  Structure and sequence of the mouse Bmp6 gene.

Authors:  S E Gitelman; M Kobrin; A Lee; V Fet; K Lyons; B L Hogan; R Derynck
Journal:  Mamm Genome       Date:  1997-03       Impact factor: 2.957

2.  Phosphatidylethanolamine biomimetic coating increases mesenchymal stem cell osteoblastogenesis.

Authors:  Bérengère J C Luthringer; Uma M R Katha; Regine Willumeit
Journal:  J Mater Sci Mater Med       Date:  2014-07-01       Impact factor: 3.896

3.  BMP-6 inhibits MMP-9 expression by regulating heme oxygenase-1 in MCF-7 breast cancer cells.

Authors:  Chuan Wang; Fen Hu; Shaocong Guo; Dong Mi; Wenwen Shen; Jie Zhang; Yuhuan Qiao; Tianhui Zhu; Shuang Yang
Journal:  J Cancer Res Clin Oncol       Date:  2010-12-07       Impact factor: 4.553

4.  Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen.

Authors:  D J Rickard; L C Hofbauer; S K Bonde; F Gori; T C Spelsberg; B L Riggs
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

5.  Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells.

Authors:  Minoru Takagi; Naoko Kamiya; Tomihisa Takahashi; Shinsuke Ito; Mitsuharu Hasegawa; Naoto Suzuki; Koji Nakanishi
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

6.  Starch-poly-epsilon-caprolactone microparticles reduce the needed amount of BMP-2.

Authors:  E R Balmayor; G A Feichtinger; H S Azevedo; M van Griensven; R L Reis
Journal:  Clin Orthop Relat Res       Date:  2009-06-26       Impact factor: 4.176

7.  Quinoline compound KM11073 enhances BMP-2-dependent osteogenic differentiation of C2C12 cells via activation of p38 signaling and exhibits in vivo bone forming activity.

Authors:  Seung-hwa Baek; Sik-Won Choi; Sang-Joon Park; Sang-Han Lee; Hang-Suk Chun; Seong Hwan Kim
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

8.  Effect of 15-Deoxy-Δ12,14-prostaglandin J2Nanocapsules on Inflammation and Bone Regeneration in a Rat Bone Defect Model.

Authors:  Qi Tang; Li-Li Chen; Fen Wei; Wei-Lian Sun; Li-Hong Lei; Pei-Hui Ding; Jing-Yi Tan; Xiao-Tao Chen; Yan-Min Wu
Journal:  Chin Med J (Engl)       Date:  2017-02-05       Impact factor: 2.628

9.  Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions.

Authors:  M Blessing; P Schirmacher; S Kaiser
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

Review 10.  Evaluation of bone morphogenic proteins in periodontal practice.

Authors:  Supreet Kaur; Vishakha Grover; Harkiran Kaur; Ranjan Malhotra
Journal:  Indian J Dent       Date:  2016 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.